H2AX and central nervous system cancer: Thus, to evaluate whether axitinib treatment could trigger the DDR in glioma cells, we initially investigated the presence of γ-H2AX (H2AX), Ser139 phosphorylated variant of histone 2A associated with DNA double-strand breaks [23].